2.63 USD
↘ 0.07 (2.59%)AT CLOSE (11:59 AM EDT)
Mannkind Corporation
MNKDNASDAQ • USD
2.61
↘ 0.02 (0.57%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
2.61
↘ 0.02 (0.57%)
Market: CLOSED
Open?$2.71
High?$2.76
Low?$2.59
Prev. Close?$2.70
Volume?3.9M
Avg. Volume?5.0M
VWAP?$2.65
Rel. Volume?0.78x
Bid / Ask
Bid?$2.27 × 100
Ask?$2.99 × 100
Spread?$0.72
Midpoint?$2.63
Valuation & Ratios
Market Cap?833.7M
Shares Out?308.8M
Float?299.1M
Float %?97.4%
P/E Ratio?142.21
P/B Ratio?-16.34
EPS?$0.02
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.70Adequate
Quick Ratio?1.50Adequate
Cash Ratio?0.44Low
Debt/Equity?-8.98Low
ValuationFAIRLY VALUED
Score61/100
P/E?142.2PRICEY▾
P/B?-16.34CHEAP▾
P/S?2.39CHEAP▾
P/FCF?60.9PRICEY▾
EV/EBITDA?20.7HIGH▾
EV/Sales?3.49FAIR▾
Returns & Efficiency
ROE?-11.5%WEAK▾
ROA?0.7%WEAK▾
Cash Flow & Enterprise
FCF?$13.7M
Enterprise Value?$1.2B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
Employees
592
Market Cap
833.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2004-07-28
Address
1 CASPER STREET
DANBURY, CT 06810
Phone: 818-661-5000
DANBURY, CT 06810
Phone: 818-661-5000